The Hidden Salmon Patch: Ocular Lymphoma Mistaken as Vogt Koyanagi Disease

2016 ◽  
Vol 6 (1) ◽  
pp. 46-50
Author(s):  
Hazlita Mohd Isa ◽  
Keyword(s):  
Ocular Lymphoma

Primary Ocular Lymphoma: Clinical Features, Diagnosis, and Treatment

2003 ◽  
Vol 4 (1) ◽  
pp. 22-29 ◽  
Author(s):  
Adília Hormigo ◽  
Lisa M. DeAngelis
Keyword(s):  
Clinical Features ◽  
Diagnosis And Treatment ◽  
Ocular Lymphoma

The clinical spectrum of ocular lymphoma

Cancer ◽  
1993 ◽  
Vol 72 (3) ◽  
pp. 843-849 ◽  
Author(s):  
Kendra Peterson ◽  
Kathleen B. Gordon ◽  
Murk-Hein Heinemann ◽  
Lisa M. DeAngelis
Keyword(s):  
Clinical Spectrum ◽  
Ocular Lymphoma

Retinal Manifestations of Ocular Lymphoma (Reticulum Cell Sarcoma)

Ophthalmology ◽  
1992 ◽  
Vol 99 (7) ◽  
pp. 1153-1161 ◽  
Author(s):  
Miriam E. Ridley ◽  
H. Richard McDonald ◽  
Paul Sternberg ◽  
Mark S. Blumenkranz ◽  
Marco A. Zarbin ◽  
...  
Keyword(s):  
Reticulum Cell ◽  
Reticulum Cell Sarcoma ◽  
Cell Sarcoma ◽  
Ocular Lymphoma

POST-TRAUMATIC OCULAR LYMPHOMA IN THREE RABBITS (ORYCTOLAGUS CUNICULUS)

2019 ◽  
Vol 28 ◽  
pp. 154-161 ◽  
Author(s):  
Krista A Keller ◽  
David Sanchez-Migallon Guzman ◽  
Christopher Reilly ◽  
Beth Valentine ◽  
Felicia D Duke Boynton ◽  
...  
Keyword(s):  
Oryctolagus Cuniculus ◽  
Ocular Lymphoma ◽  
Post Traumatic

Ocular Lymphoma

2013 ◽  
pp. 185-186
Author(s):  
Pier Francesco Rambaldi
Keyword(s):  
Ocular Lymphoma

scholarly journals Survival in B-cell primary ocular lymphoma 1997–2014: a population-based study

2018 ◽  
Vol 66 (8) ◽  
pp. 1133-1140
Author(s):  
Deliang L Liu ◽  
Zhuojun J Zheng
Keyword(s):  
Prognostic Factors ◽  
B Cell ◽  
Cox Regression ◽  
Clinical Information ◽  
Population Based ◽  
Population Based Study ◽  
Ocular Lymphoma ◽  
Radiotherapy Alone ◽  
Therapeutic Measures ◽  
End Results

This study sought to explore the prognostic factors in a large retrospective cohort of patients with B-cell primary ocular lymphoma (POL) from the Surveillance, Epidemiology, and End Results database. There were 2778 patients with B-cell POL whose complete clinical information was listed in the Surveillance, Epidemiology, and End Results database between 1997 and 2014. The epidemiology, therapeutic measures, and clinical characteristics were listed as descriptive statistics. Survival analysis was conducted by univariate and multivariable Cox regression models. Multivariate analysis identified age, lymphoma subtype, primary lesion, and radiation status as independent prognostic factors. For indolent lymphoma, radical treatment, especially intravenous chemotherapy, should be avoided. For invasive lymphoma, chemotherapy combined with full orbital irradiation is recommended. Radiotherapy alone or in combination with chemotherapy is superior to chemotherapy alone. These differences were statistically significant (p<0.05). Radiation brings benefits, with tolerable neurotoxicity, to patients with invasive B-cell POL. Radical tumor treatment may not be needed for patients with indolent B-cell POL.

Optimal Therapy of Primary Ocular Lymphoma

2002 ◽  
Vol 14 (6) ◽  
pp. 521 ◽  
Author(s):  
P.N. Plowman ◽  
A. Taylor ◽  
A.S.N. Jackson ◽  
S. Lightman ◽  
C. Pavesio
Keyword(s):  
Optimal Therapy ◽  
Ocular Lymphoma

scholarly journals Ocular lymphoma with extrascleral extension as primary manifestation of Richter syndrome

Eye ◽  
2012 ◽  
Vol 26 (6) ◽  
pp. 891-893 ◽  
Author(s):  
P M Mota ◽  
W Dedes ◽  
S-l Yeoh ◽  
E Soilleux ◽  
S Hague
Keyword(s):  
Ocular Lymphoma ◽  
Richter Syndrome

scholarly journals Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma

Cancer ◽  
2005 ◽  
Vol 104 (3) ◽  
pp. 591-597 ◽  
Author(s):  
Joachim M. Baehring ◽  
Sofia Androudi ◽  
Janina J. Longtine ◽  
Rebecca A. Betensky ◽  
Jeffrey Sklar ◽  
...  
Keyword(s):  
Heavy Chain ◽  
Immunoglobulin Heavy Chain ◽  
Ocular Lymphoma
Sign in / Sign up

Export Citation Format

Share Document